Evidence map›Paper›PMID 19085229›Full record

ArticleAIDS care2009

Australian men's experiences during a microbicide male tolerance study.

Susan L Rosenthal, Wendy Holmes, Lisa Maher

Open access · greenAbstract readClinical Trial, Phase I
In one paragraph

Article in AIDS care, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Perceptions of reimbursement for clinical trial participation.Journal of empirical research on human research ethics : JERHRE · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Susan L RosenthalDepartment of Pediatrics and Sealy Center for Vaccine Development, University of Texas Medical Branch at Galveston, Galveston, TX, USA. slrosent@utmb.edu
Wendy Holmes
Lisa Maher
Burnet Institute · AUThe University of Texas Medical Branch at Galveston · USUNSW Sydney · AU

Funding

T. vaginalis Recurrence Among HIV+ WomenU19AI061972 · NIAID · LSU HEALTH SCIENCES CENTER · PI MYERS, LEANN · 2004 to 2009
$12.0M
Supplement to grant: Development of Dendrimer and Combination MicrobicidesU19AI060598 · NIAID · STARPHARMA, LTD · PI VINCENT, KATHLEEN LISTIAK · 2004 to 2009
$6.9M
MICROBICIDES: DEVELOPMENTAL CONTEXT OF ACCEPTABILITYR01HD040151 · NICHD · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ROSENTHAL, SUSAN L · 2000 to 2004
$2.0M
NIAID NIH HHS U19 AI060598NIAID NIH HHS U19 AI061972NICHD NIH HHS R01 HD040151NICHD NIH HHS R01 HD40151-01PHS HHS HHSN 266200500042C
6 · The paper itself

Abstract

Microbicides currently in development have the potential to provide new options for the prevention of sexually transmitted infections if proven safe and efficacious. We examined the experiences of healthy male volunteers in a male tolerance study in Victoria, Australia in relation to trial participation and product use. Men (N=36) enrolled in a seven-day, phase 1 clinical safety trial of SPL7013 were interviewed pre and post-use of the gel using a semi-structured interview guide. Interviews were digitally recorded and transcribed verbatim, and transcripts were analysed using a framework approach. All but one man completed the trial. The median age was 34 years (range 22-67 years). Most men had little pre-study knowledge of microbicides and almost all participated for altruistic or personal reasons. Men expressed few concerns about product safety during the trial and indicated trust in the information received through the consent process and from study staff. Three men were non-adherent to the request to be abstinent and an additional two did not refrain from masturbation. Most were positive about the gel, although they described it as "sticky" and found that it stuck to clothes, bed sheets and pubic hair. The type of applicator used was unfamiliar to the men, and some found it "clinical" in appearance. Men are willing to participate in male tolerance studies, often for altruistic reasons. However, counseling about ways to maintain abstinence and further research to inform anticipatory guidance regarding the "sticky" quality of gels, may be important.

Indexed as

Administration, IntravaginalAdultAgedAnti-Infective AgentsGelsHIV InfectionsHumansMaleMedication AdherenceMiddle AgedQualitative ResearchSexually Transmitted DiseasesSurveys and QuestionnairesVictoriaYoung AdultAnti-Infective AgentsGels

Identifiers

PMID19085229
PMCPMC2605281
OpenAlexW2140027395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.